What’s New in Rosacea in 2022
149221492214922
Next Steps in Derm, in partnership with ODAC Dermatology, Aesthetic and Surgical Conference, interviewed Dr. Neal Bhatia (board-certified Dermatologist who serves as Director of Clinical Dermatology at Therapeutics Clinical Research ) about exciting new developments in rosacea medications. Watch as he offers his most important advice for treating patients with this chronic skin condition.
� …
Next Steps in Derm, in partnership with ODAC Dermatology, Aesthetic and Surgical Conference, interviewed Dr. Neal Bhatia (board-certified Dermatologist who serves as Director of Clinical Dermatology at Therapeutics Clinical Research ) about exciting new developments in rosacea medications. Watch as he offers his most important advice for treating patients with this chronic skin condition.
� … 
INTRODUCTION
Mohs micrographic surgery (MMS) is increasingly utilized for treatment of skin cancer, however the technique used is markedly different than other surgical modalities.1,2 Explaining MMS to patients is difficult, and anxiety following a skin cancer diagnosis likely leads many to seek out additional resources to supplement their understanding.3,4 It is unclear how accurate and comp … 
Histologic evaluation of tissue can often be an essential partner to the clinical evaluation in reaching an accurate diagnosis of skin disease. However, clinical pathologic correlation is key for this partnership to be helpful. At ODAC 2022, Dr. Olayemi Sokumbi, dermatologist and dermatopathologist extraordinaire, highlighted this challenge with striking cases demonstrating potential pitfalls and … 
Next Steps in Derm, in partnership with ODAC Dermatology, Aesthetic and Surgical Conference, interviewed Dr. Mathew M. Avram (Director of the Mass General Dermatology Laser & Cosmetic Center and Director of Dermatologic Surgery at MGH, as well as Faculty Director for Procedural Training in Harvard Medical School's Dermatology Department), who discusses potential legal situations that may ari … 
Telogen effluvium (TE) – a common cause of non- scarring hair loss – is managed with varying clinical protocols given the paucity of evidence-based practices.
INTRODUCTION
Telogen effluvium (TE) – a common cause of non-scarring hair loss – is managed with varying clinical protocols given the paucity of evidence-based practices. While endocrine, vitamin, and mineral abnormalities … 